Raltegravir: The evidence of its therapeutic value in HIV-1 infection

由 Ramkumar, Kavya, Neamati, Nouri
出版 2010

Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors

由 Neamati Nouri, Ramkumar Kavya, Odde Srinivas, Serrao Erik
出版 2009-04-01

Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors

由 Serrao, Erik, Odde, Srinivas, Ramkumar, Kavya, Neamati, Nouri
出版 2009

Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors

由 Serrao, Erik, Odde, Srinivas, Ramkumar, Kavya, Neamati, Nouri
出版 2009

The hydroxyquinoline analog YUM70 inhibits GRP78 to induce ER stress-mediated apoptosis in pancreatic cancer

由 Samanta, Soma, Yang, Suhui, Debnath, Bikash, Xue, Ding, Kuang, Yuting, Ramkumar, Kavya, Lee, Amy S., Ljungman, Mats, Neamati, Nouri
發表在 Cancer Res (2021)

Design, Synthesis and Structure-activity Studies of Rhodanine Derivatives as HIV-1 Integrase Inhibitors

由 Ramkumar, Kavya, Yarovenko, Vladimir N., Nikitina, Alexandra S., Zavarzin, Igor V., Krayushkin, Mikhail M., Kovalenko, Leonid V., Esqueda, Adrian, Odde, Srinivas, Neamati, Nouri
發表在 Molecules (2010)

Mechanistic evaluation and transcriptional signature of a glutathione S-transferase omega 1 inhibitor

由 Ramkumar, Kavya, Samanta, Soma, Kyani, Anahita, Yang, Suhui, Tamura, Shuzo, Ziemke, Elizabeth, Stuckey, Jeanne A., Li, Si, Chinnaswamy, Krishnapriya, Otake, Hiroyuki, Debnath, Bikash, Yarovenko, Vladimir, Sebolt-Leopold, Judith S., Ljungman, Mats, Neamati, Nouri
發表在 Nat Commun (2016)

Combination treatment of the oral CHK1 inhibitor, SRA737 and low dose gemcitabine, enhances the effect of PD-L1 blockade by modulating the immune microenvironment in small cell lun...

由 Sen, Triparna, Della Corte, Carminia M., Milutinovic, Snezana, Cardnell, Robert J, Diao, Lixia, Ramkumar, Kavya, Gay, Carl M., Stewart, C Allison, Fan, Youhong, Shen, Li, Hansen, Ryan J., Strouse, Bryan, Hedrick, Michael P., Hassig, Christian A., Heymach, John V., Wang, Jing, Byers, Lauren A
發表在 J Thorac Oncol (2019)

AXL inhibition induces DNA damage and replication stress in non-small cell lung cancer cells and promotes sensitivity to ATR inhibitors

由 Ramkumar, Kavya, Stewart, C. Allison, Cargill, Kasey R., Corte, Carminia M. Della, Wang, Qi, Shen, Li, Diao, Lixia, Cardnell, Robert J., Peng, David H., Rodriguez, B. Leticia, Fan, You-Hong, Heymach, John V., Wang, Jing, Gay, Carl M., Gibbons, Don L., Byers, Lauren A.
發表在 Mol Cancer Res (2020)

STING pathway expression identifies non-small cell lung cancers with an immune-responsive phenotype

由 Corte, Carminia M. Della, Sen, Triparna, Gay, Carl M., Ramkumar, Kavya, Diao, Lixia, Cardnell, Robert J., Rodriguez, B. Leticia, Stewart, C. Allison, Papadimitrakopoulou, Vassiliki A., Gibson, Laura, Fradette, Jared J., Wang, Qi, Fan, Youhong, Peng, David H., Negrao, Marcelo V., Witsuba, Ignacio I., Fujimoto, Junya, Soto, Luisa M. Solis, Behrens, Carmen, Skoulidis, Ferdinandos, Heymach, John V., Wang, Jing, Gibbons, Don L., Byers, Lauren A.
發表在 J Thorac Oncol (2020)

Lung cancer models reveal SARS-CoV-2-induced EMT contributes to COVID-19 pathophysiology

由 Stewart, C. Allison, Gay, Carl M., Ramkumar, Kavya, Cargill, Kasey R., Cardnell, Robert J., Nilsson, Monique B., Heeke, Simon, Park, Elizabeth M., Kundu, Samrat T., Diao, Lixia, Wang, Qi, Shen, Li, Xi, Yuanxin, Zhang, Bingnan, Della Corte, Carminia Maria, Fan, Youhong, Kundu, Kiran, Gao, Boning, Avila, Kimberley, Pickering, Curtis R., Johnson, Faye M., Zhang, Jianjun, Kadara, Humam, Minna, John D., Gibbons, Don L., Wang, Jing, Heymach, John V., Byers, Lauren Averett
發表在 bioRxiv (2021)

Lung Cancer Models Reveal Severe Acute Respiratory Syndrome Coronavirus 2–Induced Epithelial-to-Mesenchymal Transition Contributes to Coronavirus Disease 2019 Pathophysiology

由 Stewart, C. Allison, Gay, Carl M., Ramkumar, Kavya, Cargill, Kasey R., Cardnell, Robert J., Nilsson, Monique B., Heeke, Simon, Park, Elizabeth M., Kundu, Samrat T., Diao, Lixia, Wang, Qi, Shen, Li, Xi, Yuanxin, Zhang, Bingnan, Della Corte, Carminia Maria, Fan, Youhong, Kundu, Kiran, Gao, Boning, Avila, Kimberley, Pickering, Curtis R., Johnson, Faye M., Zhang, Jianjun, Kadara, Humam, Minna, John D., Gibbons, Don L., Wang, Jing, Heymach, John V., Byers, Lauren Averett
發表在 J Thorac Oncol (2021)

Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities

由 Gay, Carl M., Allison Stewart, C., Park, Elizabeth M., Diao, Lixia, Groves, Sarah M., Heeke, Simon, Nabet, Barzin Y., Fujimoto, Junya, Solis, Luisa M., Lu, Wei, Xi, Yuanxin, Cardnell, Robert J., Wang, Qi, Fabbri, Giulia, Cargill, Kasey R., Vokes, Natalie I., Ramkumar, Kavya, Zhang, Bingnan, Della Corte, Carminia M., Robson, Paul, Swisher, Stephen G., Roth, Jack A., Glisson, Bonnie S., Shames, David S., Wistuba, Ignacio I., Wang, Jing, Quaranta, Vito, Minna, John, Heymach, John V., Byers, Lauren Averett
發表在 Cancer Cell (2021)